| Serial Number | 97635376 |
| Word Mark | CRISPR THERAPEUTICS DE&I IT'S IN OUR DNA DIVERSITY, EQUITY, AND INCLUSION |
| Filing Date | Monday, October 17, 2022 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Thursday, May 9, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 3, 2023 |
| Goods and Services | Education services, namely, providing on-line non-downloadable articles and newsletters in the field of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy |
| Pseudo Mark | CRISPR THERAPEUTICS DE AND I IT IS IN OUR DNA DIVERSITY EQUITY AND INCLUSION |
| Section 2(f) Limitation Statement | as to "CRISPR THERAPEUTICS" has become distinctive of the goods/services through the applicant's substantially exclusive and continuous use of the mark in commerce that the U.S. Congress may lawfully regulate for at least the five years immediately before the date of this statement; CRISPR THERAPEUTICS has become distinctive of the goods/services as evidenced by the ownership on the Principal Register for the same mark for sufficiently similar goods/services of active U.S. Registration No(s). 6724517 |
| Goods and Services | Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 1, 2022 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, November 1, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | CRISPR Therapeutics AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | ZUG V8 SWITZERLAND 6300 CH |
| Party Name | CRISPR Therapeutics AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | ZUG V8 SWITZERLAND 6300 CH |
| Event Date | Event Description |
| Thursday, October 20, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, October 20, 2022 | NEW APPLICATION ENTERED |
| Thursday, October 20, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, October 20, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, November 1, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, March 31, 2023 | ASSIGNED TO EXAMINER |
| Friday, March 31, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, March 31, 2023 | NON-FINAL ACTION E-MAILED |
| Friday, March 31, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, June 30, 2023 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Friday, June 30, 2023 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Tuesday, July 18, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, July 18, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, July 18, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, August 30, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, September 13, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, October 3, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, October 3, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, May 9, 2024 | SOU EXTENSION 1 FILED |
| Thursday, May 9, 2024 | SOU EXTENSION 1 GRANTED |
| Thursday, May 9, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, November 28, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, May 10, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |